|
Q4 2023
|
74 |
2,743,946 |
ARVN, BSX, CI calls, TMO
|
13F-HR
|
2/14/2024 |
000179182724000002 |
|
Q3 2023
|
83 |
2,483,190 |
BSX, JAZZ, BDX, NBIX
|
13F-HR
|
11/14/2023 |
000179182723000006 |
|
Q2 2023
|
93 |
2,863,157 |
BDX, KRTX, JAZZ, GEHC
|
13F-HR
|
8/14/2023 |
000179182723000004 |
|
Q1 2023
|
83 |
3,012,659 |
ARVN, SGRY, BIO, ARGX
|
13F-HR
|
5/15/2023 |
000179182723000003 |
|
Q4 2022
|
85 |
4,615,991 |
XBI calls, ARGX, UTHR, NBIX
|
13F-HR
|
2/14/2023 |
000179182723000002 |
|
Q3 2022
|
97 |
4,918,761 |
LLY, SPDR SER TR calls, UTHR, NBIX
|
13F-HR
|
11/14/2022 |
000179182722000008 |
|
Q2 2022
|
82 |
4,355,880 |
AZN, VRTX, ARGX, ELV
|
13F-HR
|
8/15/2022 |
000179182722000006 |
|
Q1 2022
|
92 |
4,802,645 |
SPDR SER TR calls, AZN, ABBV, ARVN
|
13F-HR
|
5/16/2022 |
000179182722000004 |
|
Q4 2021
|
97 |
4,714,958 |
ABBV, ZNTL, ARVN, AVTR
|
13F-HR
|
2/14/2022 |
000179182722000002 |
|
Q3 2021
|
105 |
4,513,577 |
XBI calls, XLRN calls, MRTX, ARVN
|
13F-HR
|
11/15/2021 |
000179182721000006 |
|
Q2 2021
|
112 |
3,699,847 |
VRTX, ABBV, ARVN, LLY
|
13F-HR
|
8/16/2021 |
000179182721000005 |
|
Q1 2021
|
94 |
3,619,767 |
ABBV, AZN, AVTR, MDT
|
13F-HR
|
5/17/2021 |
000179182721000004 |
|
Q4 2020
|
96 |
3,080,209 |
AVTR, ARVN, ABBV, LLY
|
13F-HR
|
2/16/2021 |
000179182721000002 |
|
Q3 2020
|
68 |
2,155,960 |
PFIZER INC calls, ABBV, SGEN, AVTR
|
13F-HR
|
11/16/2020 |
000179182720000006 |
|
Q2 2020
|
57 |
1,560,198 |
ABBV, REGN, BIOHAVEN PHARMACTL HLDG CO L, BAX
|
13F-HR
|
8/14/2020 |
000179182720000004 |
|
Q1 2020
|
52 |
723,593 |
SGEN, MRK, ABBV, MCK
|
NEW HOLDINGS
|
6/17/2020 |
000091957420004168 |
|
Q1 2020
|
1 |
0 |
|
13F-HR
|
5/15/2020 |
000091957420003442 |
|
Q4 2019
|
33 |
158,691 |
BAX, HCA, VRTX, ABBV
|
NEW HOLDINGS
|
6/17/2020 |
000091957420004167 |
|
Q4 2019
|
1 |
0 |
|
13F-HR
|
2/14/2020 |
000091957420001350 |